By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...

During the last three months, 4 analysts shared their evaluations of Moderna (NASDAQ: MRNA ), revealing diverse outlooks from ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo ...

The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

When the Pfizer-BioNTech COVID-19 vaccine was authorized for emergency use by the Food and Drug Administration (FDA) in December 2020, President Donald Trump referred to it as a "medical miracle." ...